Anti-inflammatory therapies that are highly effective for inflammatory skin diseases might also be relevant to depression because of shared inflammatory pathways.

Patients with MDD exhibit significantly higher triglyceride levels, which correlate with worse functional impairment scores.

Researchers have discovered a surprising change in how cells produce energy in people with depression. Brain and blood cells in young adults with major depressive disorder produced more energy ...

Major depressive disorder study reveals shared brain and blood biomarkers, opening paths for precision diagnosis and targeted ...

Compared with healthy individuals, those with major depressive disorder and bipolar disorder exhibit reduced amygdala-fronto-limbic connectivity.

Patients with major depressive disorder and patients with inflammatory skin diseases like atopic dermatitis share similar ...

Depression-related fatigue is caused by cellular "overworking" at rest and a failure to produce energy under stress.

Axsome Therapeutics has begun the Phase 3 CLARITY trial of solriamfetol in adults with major depressive disorder and excessive daytime sleepiness. The study focuses on a patient group that currently ...

Please provide your email address to receive an email when new articles are posted on . Among 336 patients with asthma, 46 also had major depressive disorder. There were longitudinal associations ...

Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for a third and potentially most lucrative indication—major depressive disorder ...

No statistically significant change in MADRS total score was observed with solriamfetol vs placebo in the overall study population. Topline results were announced from a phase 3 trial evaluating ...